Myasthenia gravis induced by nivolumab therapy in a patient with non–small‐cell lung cancer
2016; Wiley; Volume: 54; Issue: 3 Linguagem: Inglês
10.1002/mus.25163
ISSN1097-4598
AutoresPınar Polat, Peter D. Donofrio,
Tópico(s)Cancer Immunotherapy and Biomarkers
ResumoMuscle & NerveVolume 54, Issue 3 p. 507-507 Noteworthy Cases Myasthenia gravis induced by nivolumab therapy in a patient with non–small-cell lung cancer Pinar Polat MD, MPH, Pinar Polat MD, MPH Department of Pediatric Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USASearch for more papers by this authorPeter D. Donofrio MD, Peter D. Donofrio MD Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USASearch for more papers by this author Pinar Polat MD, MPH, Pinar Polat MD, MPH Department of Pediatric Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USASearch for more papers by this authorPeter D. Donofrio MD, Peter D. Donofrio MD Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USASearch for more papers by this author First published: 27 April 2016 https://doi.org/10.1002/mus.25163Citations: 50Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume54, Issue3September 2016Pages 507-507 RelatedInformation
Referência(s)